X0206 3 2021-07-27 0 0001863294 DA32 Life Science Tech Acquisition Corp. DALS 0001219039 CRANDELL KEITH DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 100100 1 0 1 0 Class B Common Stock Class A Common Stock 30000 D Class B Common Stock Class A Common Stock 5166250 I Through DA32 Sponsor LLC The Reporting Person directly owns 30,000 shares of Class B Common Stock, which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date. DA32 Sponsor LLC ("Sponsor") is the record holder of the securities reported herein. As a managing member of Sponsor, ARCH Venture Fund XI, L.P. ("AVF") may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVF, ARCH Venture Partners XI, L.P. ("AVP LP") may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVP LP, ARCH Venture Partners XI, LLC ("AVP LLC") may be deemed to beneficially own securities owned directly by Sponsor. As the members of the investment committee, each of Kristina Burow, Robert Nelsen, Keith Crandell and Steven Gillis may be deemed to beneficially own securities owned directly by Sponsor. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein. The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date. The shares of Class B Common Stock beneficially owned by the Reporting Person include up to 750,000 shares of Class B Common Stock subject to forfeiture to the Issuer depending on the extent to which the underwriters' over-allotment option is exercised in connection with the Issuer's initial public offering of Class A Common Stock, as described in the Registration Statement. See Exhibit 24.1 - Power of Attorney. /s/ Henrikki Harsu, Attorney-in-Fact 2021-07-27